| 论文标题 | 作者 | 发表时间 | 发表杂志 | 影响因子 |
|---|---|---|---|---|
| Targeting THR β for MASLD Treatment: Current Progression and Emerging Prospects | Li J, Chen R, Zhang J, He J, Wang Y, Li Y |
2026-01 |
Journal of medicinal chemistry |
6.8 |
| Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosis | Zobair M YounossiFatema NaderDominic LabriolaRebecca TaubAndrei RacilaLinda HenryMaria Stepanova |
2026-02 |
Hepatology communications |
4.6 |
| Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night | Marjot T, Smith K, Westcott F, White S, Johnson E, Srnic N, Barrett A, Hall E, Gralton K, Dennis K, Miller H, Pofi R, Cobbold JFL, Richmond R, Karpe F, Blazev R, Watt MJ, Parker BL, Hodson L, Ray DW, Tomlinson JW |
2026-01 |
Cell metabolism |
30.9 |
| Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directions | Huei-Tyng Huang ,Michael Hewitt ,Wenhao Li ,William Alazawi |
2025-12 |
The Lancet regional health. Europe |
13 |
| Global Performance of Non-invasive Tests in MASLD: Insights from the G-MASLD Study | Younossi, Z. M., de Avila, L., Petta, S., Hagström, H., Kim, S. U., Nakajima, A., Crespo, J., Castera, L., Alkhouri, N., Zheng, M. H., Treeprasertsuk, S., Ananchuensook, P., Shalimar, Tsochatzis, E., Trivikrama, S. K., Balakumaran, L. K., Fan, J. G., Roberts, S. K., Alswat, K., Wong, V. W |
2025-10 |
Hepatology (Baltimore, Md.) |
15.8 |
| Reprogramming offspring liver health: maternal indole supplementation as a preventive strategy against MASLD | Ashok Mandala,Ram Babu Undi,Rachel C Janssen,Kameron Y Sugino,Wanke Zhao,Benjamin N Nelson,April M Teague,Nikhil Y Patil,Karin Zemsky Berry,Rohan Varshney,Bryan C Bergman,Michael C Rudolph,Aditya D Joshi,Raju V S Rajala,Karen R Jonscher,Jacob E Friedman |
2025-12 |
EBioMedicine |
10.8 |
| Predictors of Fibrosis, Clinical Events and Mortality in MASLD: Data from the GlobalMASLD Study | Younossi ZM, de Avila L, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Ananchuensook P, Shalimar, Tsochatzis E, Trivikrama SK, Balakumaran LK, Fan JG, Roberts SK, Alswat K, Wong VW, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Goh GB, Oliveira CP, Pessoa MG, Chan WK, Fernandez MIC, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, Alnaamani K, Holleboom AG, Valsan A, Venu A, El-Kassas M, Pennisi G, Shang Y, Liu WY, Lee HW, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Iruzubieta P, Nadeem R, Cinque F, Neonaki A, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, The KK, Mahadeva S, Fabian LG, Almohsen A, Leite N, Pugliese N, Vessby J, Xie C, Choudhary NS, Friend E, Poca M, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Segrestin B, Gunn N, Mauricio D, Arrese M, Fracanzani A, Lam B, Racila A, Alqahtani SA, Stepanova M |
2025-11 |
Hepatology (Baltimore, Md.) |
15.8 |
| Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study | Jeffrey V Lazarus ,Leire Agirre-Garrido ,Trenton M White ,Anish K Arora ,Melina I Manolas ,Luis Antonio Diaz ,Juan Pablo Arab ,Shira Zelber-Sagi ,Naim Alkhouri ,C Wendy Spearman,Jörn M Schattenberg,Loreta A Kondili,Patrizia Carrieri,Holly F Lofton,Priya Jaisinghani,Sonal Kumar,Ajay Duseja,Mohamed El-Kassas,Hirokazu Takahasi,Debbie L Shawcross,Jonathan G Stine,Marcela Villota-Rivas,Juan Emilio Miralles-Sanchez,Silvana Pannain,Paul N Brennan,MASLD/MASH Collaborators |
2025-12 |
The lancet. Gastroenterology & hepatology |
38.6 |
| Hepatic Insulin Resistance and Steatosis in Metabolic DysfunctionAssociated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications | Xuan Trong Truong , Dae Ho Lee |
2025-09 |
Diabetes & metabolism journal |
8.5 |
| Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis | Wenhao Li , William Alazawi , Rohit Loomba |
2025-11 |
The lancet. Gastroenterology & hepatology |
38.6 |